Article ; Online: Bilateral acute depigmentation of the iris (BADI) and bilateral acute iris transillumination (BAIT): A case series from a center in Brazil.
Arquivos brasileiros de oftalmologia
2024 Volume 87, Issue 4, Page(s) e2023
Abstract: Bilateral acute depigmentation of the iris and bilateral acute iris transillumination (BAIT) are similar clinical entities. The former causes acute-onset depigmentation of the iris stroma without transillumination, whereas the latter causes ... ...
Abstract | Bilateral acute depigmentation of the iris and bilateral acute iris transillumination (BAIT) are similar clinical entities. The former causes acute-onset depigmentation of the iris stroma without transillumination, whereas the latter causes depigmentation of the iris pigment epithelium with transillumination. The etiopathogenesis of these conditions is not yet fully understood, but the proposed causes include the use of systemic antibiotics (especially moxifloxacin) and viral triggers. We present a case series of five female patients with a mean age of 41 (32-45) years, all of whom suffered acute onset of bilateral pain and redness of the eyes after moxifloxacin use (oral or topical). It is important for ophthalmologists to be aware of the two forms of iris depigmentation since this case series suggests that SARS-CoV-2 or its empirical treatment with moxifloxacin may trigger iris depigmentation. If this is the case, clinicians will likely see increased incidences of bilateral acute depigmentation of the iris and bilateral acute iris transillumination during and after the COVID-19 pandemic. |
---|---|
MeSH term(s) | Humans ; Female ; Adult ; Iris Diseases/chemically induced ; Middle Aged ; COVID-19/complications ; Brazil ; Acute Disease ; Moxifloxacin/adverse effects ; Moxifloxacin/therapeutic use ; Transillumination ; SARS-CoV-2 ; Pigmentation Disorders/chemically induced ; Iris/pathology ; Anti-Bacterial Agents/adverse effects ; Pigment Epithelium of Eye/pathology ; Pigment Epithelium of Eye/drug effects |
Chemical Substances | Moxifloxacin (U188XYD42P) ; Anti-Bacterial Agents |
Language | English |
Publishing date | 2024-04-19 |
Publishing country | Brazil |
Document type | Case Reports |
ZDB-ID | 603915-7 |
ISSN | 1678-2925 ; 0004-2749 |
ISSN (online) | 1678-2925 |
ISSN | 0004-2749 |
DOI | 10.5935/0004-2749.2023-0219 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.B 503: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MO 317: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.